Literature DB >> 24369387

Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.

Janet R Cummings1, Hefei Wen1, Michelle Ko2, Benjamin G Druss1.   

Abstract

IMPORTANCE: Although substance use disorders (SUDs) are prevalent and associated with adverse consequences, treatment rates remain low. Unlike physical and mental health problems, treatment for SUDs is predominantly provided in a separate specialty sector and more heavily financed by public sources. Medicaid expansion under the Patient Protection and Affordable Care Act has the potential to increase access to treatment for SUDs but only if an infrastructure exists to serve new enrollees.
OBJECTIVE: To examine the availability of outpatient SUD treatment facilities that accept Medicaid across US counties and whether counties with a higher percentage of racial/ethnic minorities are more likely to have gaps in this infrastructure. DESIGN, SETTING, AND PARTICIPANTS: We used data from the 2009 National Survey of Substance Abuse Treatment Services public use file and the 2011-2012 Area Resource file to examine sociodemographic factors associated with county-level access to SUD treatment facilities that serve Medicaid enrollees. Counties in all 50 states were included. We estimated a probit model with state indicators to adjust for state-level heterogeneity in demographics, politics, and policies. Independent variables assessed county racial/ethnic composition (ie, percentage black and percentage Hispanic), percentage living in poverty, percentage living in a rural area, percentage insured with Medicaid, percentage uninsured, and total population. MAIN OUTCOMES AND MEASURES: Dichotomous indicator for counties with at least 1 outpatient SUD treatment facility that accepts Medicaid.
RESULTS: Approximately 60% of US counties have at least 1 outpatient SUD facility that accepts Medicaid, although this rate is lower in many Southern and Midwestern states than in other areas of the country. Counties with a higher percentage of black (marginal effect [ME],  -3.1; 95% CI,  -5.2% to -0.9%), rural (-9.2%; -11.1% to -7.4%), and/or uninsured (-9.5%; -13.0% to -5.9%) residents are less likely to have one of these facilities. CONCLUSIONS AND RELEVANCE: The potential for increasing access to SUD treatment via Medicaid expansion may be tempered by the local availability of facilities to provide care, particularly for counties with a high percentage of black and/or uninsured residents and for rural counties. Although states that opt in to the expansion will secure additional federal funds for the SUD treatment system, additional policies may need to be implemented to ensure that adequate geographic access exists across local communities to serve new enrollees.

Entities:  

Mesh:

Year:  2014        PMID: 24369387      PMCID: PMC4039494          DOI: 10.1001/jamapsychiatry.2013.3575

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  21 in total

1.  Reductions in criminal convictions after addiction treatment: 5-year follow-up.

Authors:  Michael Gossop; Katia Trakada; Duncan Stewart; John Witton
Journal:  Drug Alcohol Depend       Date:  2005-03-26       Impact factor: 4.492

2.  Community residential segregation and the local supply of federally qualified health centers.

Authors:  Michelle Ko; Ninez A Ponce
Journal:  Health Serv Res       Date:  2012-07-20       Impact factor: 3.402

3.  Racial/ethnic differences in treatment for substance use disorders among U.S. adolescents.

Authors:  Janet R Cummings; Hefei Wen; Benjamin G Druss
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-10-22       Impact factor: 8.829

4.  The relationship of inpatient racial composition and hospital closure in New York City.

Authors:  A Schatzkin
Journal:  Med Care       Date:  1984-05       Impact factor: 2.983

Review 5.  Contemporary addiction treatment: a review of systems problems for adults and adolescents.

Authors:  A Thomas McLellan; Kathleen Meyers
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

6.  A 33-year follow-up of narcotics addicts.

Authors:  Y I Hser; V Hoffman; C E Grella; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  2001-05

Review 7.  Infectious diseases and drug abuse. Prevention and treatment in the drug abuse treatment system.

Authors:  H W Haverkos
Journal:  J Subst Abuse Treat       Date:  1991

8.  Geography and the Medicaid mental health care infrastructure: implications for health care reform.

Authors:  Janet R Cummings; Hefei Wen; Michelle Ko; Benjamin G Druss
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

9.  The role of black and Hispanic physicians in providing health care for underserved populations.

Authors:  M Komaromy; K Grumbach; M Drake; K Vranizan; N Lurie; D Keane; A B Bindman
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

10.  Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.

Authors:  Ramin Mojtabai; Joshua Graff Zivin
Journal:  Health Serv Res       Date:  2003-02       Impact factor: 3.402

View more
  56 in total

1.  Effect of Medicaid Expansions on Health Insurance Coverage and Access to Care among Low-Income Adults with Behavioral Health Conditions.

Authors:  Hefei Wen; Benjamin G Druss; Janet R Cummings
Journal:  Health Serv Res       Date:  2015-11-09       Impact factor: 3.402

2.  Not Near Enough: Racial and Ethnic Disparities in Access to Nearby Behavioral Health Care and Primary Care.

Authors:  Lynn M Wielen; Emma C Gilchrist; Molly A Nowels; Stephen M Petterson; George Rust; Benjamin F Miller
Journal:  J Health Care Poor Underserved       Date:  2015-08

3.  Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder.

Authors:  Elizabeth E Krans; Joo Yeon Kim; Alton Everette James; David Kelley; Marian P Jarlenski
Journal:  Obstet Gynecol       Date:  2019-05       Impact factor: 7.661

4.  Probability and predictors of treatment-seeking for substance use disorders in the U.S.

Authors:  Carlos Blanco; Miren Iza; Jorge Mario Rodríguez-Fernández; Enrique Baca-García; Shuai Wang; Mark Olfson
Journal:  Drug Alcohol Depend       Date:  2015-02-09       Impact factor: 4.492

5.  Providing a framework for assessment of the access to medicine.

Authors:  Monireh Afzali; Elahe Khorasani; Mahdi Alvandi; Mansoureh Sabbagh-Bani-Azad; Zahra Sharif; Parisa Saiyarsarai; Shekoufeh Nikfar
Journal:  Daru       Date:  2019-05-04       Impact factor: 3.117

6.  Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees.

Authors:  Amanda J Abraham; Christina M Andrews; Marissa E Yingling; Jerry Shannon
Journal:  Health Serv Res       Date:  2017-03-27       Impact factor: 3.402

7.  County-level access to opioid use disorder medications in medicare Part D (2010-2015).

Authors:  Amanda J Abraham; Grace Bagwell Adams; Ashley C Bradford; William D Bradford
Journal:  Health Serv Res       Date:  2019-01-21       Impact factor: 3.402

8.  Medicaid Expenditures for Fee-for-Service Enrollees with Behavioral Diagnoses: Findings from a 50 State Claims Analysis.

Authors:  Martha C Ward; Cathy Lally; Benjamin G Druss
Journal:  Community Ment Health J       Date:  2016-06-15

9.  Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.

Authors:  Scott E Hadland; J Frank Wharam; Mark A Schuster; Fang Zhang; Jeffrey H Samet; Marc R Larochelle
Journal:  JAMA Pediatr       Date:  2017-08-01       Impact factor: 16.193

10.  Disparities in the Treatment of Substance Use Disorders: Does Where You Live Matter?

Authors:  Andrea Acevedo; Lee Panas; Deborah Garnick; Dolores Acevedo-Garcia; Jennifer Miles; Grant Ritter; Kevin Campbell
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.